High dose methotrexate based chemotherapy in renal transplant recipients with primary central nervous system lymphoma.

被引：0
|
作者：
Chitalkar, PG
Kapur, B
Rajvanshi, A
Munshi, N
机构：
[1] Command Hosp, Dept Med Oncol, Pune, Maharashtra, India
[2] Command Hosp, Dept Nephrol, Pune, Maharashtra, India
[3] Inlaks & Budhrani Hosp, Dept Clin Pathol, Pune, Maharashtra, India
来源：
BLOOD | 2003年 / 102卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4862
引用
收藏
页码：285B / 285B
页数：1
相关论文
共 50 条
  • [1] Role of chemotherapy additional to high-dose methotrexate for primary central nervous system lymphoma (PCNSL)
    Bergner, Nicole
    Monsef, Ina
    Illerhaus, Gerald
    Engert, Andreas
    Skoetz, Nicole
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2012, (11):
  • [2] Rituximab with high-dose methotrexate in primary central nervous system lymphoma
    Kansara, Roopesh
    Shenkier, Tamara N.
    Connors, Joseph M.
    Sehn, Laurie H.
    Savage, Kerry J.
    Gerrie, Alina S.
    Villa, Diego
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2015, 90 (12) : 1149 - 1154
  • [3] Polymorphisms in genes of folate metabolism and effects of high-dose methotrexate in patients with primary central nervous system lymphoma.
    Knop, S.
    Guenther, M.
    Loeffler, J.
    Meisner, C.
    Korfel, A.
    Weller, M.
    Hebart, H.
    Herrlinger, U.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 436S - 436S
  • [4] Polymorphisms in genes of folate metabolism and response to high-dose methotrexate in patients with primary central nervous system lymphoma.
    Knop, S
    Loeffler, J
    Steffens, M
    Guenther, M
    Korfel, A
    Weller, M
    Hebart, H
    Einsele, H
    Herrlinger, U
    [J]. BLOOD, 2005, 106 (11) : 188B - 188B
  • [5] High-dose methotrexate based chemotherapy with deferred radiation for treatment of newly diagnosed primary central nervous system lymphoma
    Gerard, Lauren M.
    Imrie, Kevin R.
    Mangel, Joy
    Buckstein, Rena
    Doherty, Mary
    Mackenzie, Robert
    Cheung, Matthew C.
    [J]. LEUKEMIA & LYMPHOMA, 2011, 52 (10) : 1882 - 1890
  • [6] Radiomic prediction for durable response to high-dose methotrexate-based chemotherapy in primary central nervous system lymphoma
    Li, Haoyi
    Xiong, Mingming
    Li, Ming
    Sun, Caixia
    Zheng, Dao
    Yuan, Leilei
    Chen, Qian
    Lin, Song
    Liu, Zhenyu
    Ren, Xiaohui
    [J]. CANCER MEDICINE, 2024, 13 (17):
  • [7] High-dose methotrexate dosing strategy in primary central nervous system lymphoma
    Wang, Alexander
    Cirrone, Frank
    De los Reyes, Francis Andrew
    Papadopoulos, John
    Saint Fleur-Lominy, Shella
    Xiang, Elaine
    [J]. LEUKEMIA & LYMPHOMA, 2022, 63 (06) : 1348 - 1355
  • [8] Hepatotoxicity from high-dose methotrexate in primary central nervous system lymphoma
    Zhang, Joy C.
    Stotts, Matthew J.
    Horton, Bethany
    Schiff, David
    [J]. NEURO-ONCOLOGY PRACTICE, 2023, 10 (03) : 291 - 300
  • [9] HEPATOTOXICITY FROM HIGH-DOSE METHOTREXATE IN PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA
    Zhang, Joy C.
    Horton, Bethany J.
    Stotts, Matthew J.
    Schiff, David
    [J]. GASTROENTEROLOGY, 2022, 162 (07) : S1284 - S1285
  • [10] Analysis of high-dose methotrexate with rituximab versus other treatment regimens for primary central nervous system (CNS) lymphoma.
    Lindhorst, Scott Michael
    McSherry, Frances
    Desjardins, Annick
    Friedman, Henry S.
    Peters, Katherine B.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
12345